Identification of Cryptosporidium parvum dihydrofolate reductase inhibitors by complementation in Saccharomyces cerevisiae

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 4, 2000, Pages 1019-1028

  Brophy, Victoria Hertle ^a   Vasquez, John ^b   Nelson, Richard G ^b   Forney, John R ^c   Rosowsky, Andre ^d   Sibley, Carol Hopkins ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE INHIBITOR; TRIMETHOPRIM; TRIMETHOPRIM DERIVATIVE;

ANTIFUNGAL ACTIVITY; ARTICLE; CRYPTOSPORIDIUM PARVUM; FUNGUS IDENTIFICATION; NONHUMAN; PLASMODIUM FALCIPARUM; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; TOXOPLASMA GONDII;

ALLELES; ANIMALS; CRYPTOSPORIDIUM PARVUM; FOLIC ACID ANTAGONISTS; GENETIC COMPLEMENTATION TEST; HUMANS; PLASMIDS; PLASMODIUM FALCIPARUM; SACCHAROMYCES CEREVISIAE; TETRAHYDROFOLATE DEHYDROGENASE; TOXOPLASMA;

EID: 0034063524     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.4.1019-1028.2000     Document Type: Article

References (66)

1. Ahrweiler, P. M., and C. Frieden. 1988. Construction of a fol mutant strain of Escherichia coli for use in dihydrofolate reductase mutagenesis experiments. J. Bacteriol. 170:3301-3304.
2. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Strahl (ed.), 1991. Current protocols in molecular biology, vol. 2. J. Wiley, New York, N.Y.
3. Blakley, R. L. 1995. Eukaryotic dihydrofolate reductase, vol. 70. p. 23-102. John Wiley & Sons, New York, N.Y.
4. Bonnin, A., M. N. Fourmaux, J. F. Dubremetz, R. G. Nelson, P. Gobet, G. Harly, M. Buisson, D. Puygauthier-Toubas, G. Gabriel-Pospisil, M. Naciri, and P. Camerlynck. 1996. Genotyping human and bovine isolates of Cryptosporidium parvum by polymerase chain reaction-restriction fragment length polymorphism analysis of a repetitive DNA sequence. FEMS Microbiol. Lett. 137:207-211.
5. Bowden, K., N. V. Harris, and C. A. Watson. 1993. Structure-activity relationships of dihydrofolate reductase inhibitors. J. Chemother. 5:377-388.
6. Bzik, D. J., W. B. Li, T. Horii, and J. Inselburg. 1987. Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. Proc. Natl. Acad. Sci. USA 84:8360-8364.
7. Camenisch, G., G. Folkers, and H. van de Waterbeemd. 1996. Review of theoretical passive drug absorption models: historical background, recent developments and limitations. Pharm. Acta Helv. 71:309-327.
8. Carraway, M., S. Tzipori, and G. Widmer. 1996. Identification of genetic heterogeneity in the Cryptosporidium parvum ribosomal repeat. Appl. Environ. Microbiol. 62:712-716.
9. Chen, B. K., C. Horvath, and J. R. Bertino. 1979. Multivariate analysis and quantitative structure-activity relationships. Inhibition of dihydrofolate reductase and thymidylate synthetase by quinazolines. J. Med. Chem. 22:483-491.
10. Current, W. L. 1989. Cryptosporidium spp., p. 281-341. In P. D. Walzer and R. M. Genta (ed.), Parasitic infections in the compromised host. Marcel Dekker, New York, N.Y.
11. Current, W. L., N. C. Reese. J. V. Ernst, W. S. Bailey, M. B. Heyman, and W. M. Weinstein. 1983. Human cryptosporidiosis in immunocompetent and immunodeficient persons. Studies of an outbreak and experimental transmission. N. Engl. J. Med. 308:1252-1257.
12. Edman, J. C., U. Edman, M. Cao, B. Lundgren, J. A. Kovacs, and D. V. Santi. 1989. Isolation and expression of the Pneumocystis carinii dihydrofolate reductase gene. Proc. Natl. Acad. Sci. USA 86:8525-8629.
13. Falco, E. A., G. H. Hitchings, P. B. Russell, and H. Vander Werff. 1949. Antimalarials as antagonists of purines and pteroylglutamic acid. Nature (London) 164:107-108.
14. Genther, C. S., R. S. Schoeny, J. C. Loper, and C. C. Smith. 1977. Antifolate studies. Activities of 40 potential antimalarial compounds against sensitive and chlorguanide triazine resistant strains of folate-requiring bacteria and Escherichia coli. J. Med. Chem. 20:237-243.
15. Goffeau, A., B. G. Barrell, H. Bussey, R. W. Davis, B. Dujon, H. Feldmann, F. Galibert, J. D. Hoheisel, C. Jacq, M. Johnston, E. J. Louis, H. W. Mews, Y. Murakami, P. Philippsen, H. Tettelin, and S. G. Oliver. 1996. Life with 6000 genes. Science 274:546, 563-567.
16. Grindley, G., R. Moran, and W. C. Werkheiser. 1975. Drug design, vol 5. Academic Press. New York, N.Y.
17. Grunberg, E., and W. F. DeLorenzo. 1966. Potentiation of sulfonamides and antibiotics by trimethoprim [2,4-diamino-5-(3,4,5-trimethoxybenzyl) pyrimidine]. Antimicrob. Agents Chemother. 6:430-433.
18. Guerrant, R. L. 1997. Cryptosporidiosis: an emerging, highly infectious threat. Emerg. Infect. Dis. 3:51-57.
19. Guthrie, C., and G. R. Fink. 1991. Guide to yeast genetics and molecular biology. Academic Press, San Diego, Calif.
20. Hitchings, G. H., G. B. Elion, and S. Slinger. 1954. Chemistry and biology of Pteridines. Ciba Found. Symp. 1954:290.
21. Hoepelman, I. M. 1996. Human Cryptosporidiosis. Int. J. STD Aids 7(Suppl. 1):28-33.
22. Hoffman, C. S., and F. Winston. 1987. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene 57:267-272.
23. Huang, T., B. J. Barclay, T. I. Kalman, R. C. von Borstel, and P. J. Hastings. 1992. The phenotype of a dihydrofolate reductase mutant of Saccharomyces cerevisiae. Gene 121:167-171.
24. Ito, H., Y. Fukuda, K. Murata, and A. Kimura. 1983. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153:163-168.
25. Koch, K. L., D. J. Phillips, R. C. Aber, and W. L. Current. 1985. Cryptosporidiosis in hospital personnel. Evidence for person-to-person transmission. Ann. Intern. Med. 102:593-596.
26. Kunz, B. A., G. R. Taylor, and R. H. Haynes. 1986. Induction of intrachromosomal recombination in yeast by inhibition of thymidylate biosynthesis. Genetics 114:375-392.
27. Kuyper, L. F., D. P. Baccanari, M. L. Jones, R. N. Hunter, R. L. Tansik, S. S. Joyner, C. M. Boytos, S. K. Rudolph, V. Knick, H. R. Wilson, J. M. Caddell, H. S. Friedman, J. C. Comley, and J. N. Stables. 1996. High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with small molecular size. J. Med. Chem. 39:892-903.
28. Lagosky, P. A., G. R. Taylor, and R. H. Haynes. 1987. Molecular characterization of the Saccharomyces cerevisiae dihydrofolate reductase gene (DFR1). Nucleic Acids Res. 15:10355-10371.
29. Lane, B. R., J. C. Ast, P. A. Hossler, D. P. Mindell, M. S. Bartlett, J. W. Smith, and S. R. Meshnick. 1997. Dihydropteroate synthase polymorphisms in Pneumocystis carinii. J. Infect. Dis. 175:482-485.
30. Lemeteil, D., F. Roussel, L. Favennec, J. J. Ballet, and P. Brasseur. 1993. Assessment of candidate anticryptosporidial agents in an immunosuppressed rat model. J. Infect. Dis. 167:766-768.
31. Marshall, M. M., D. Naumovitz, Y. Ortega, and C. R. Sterling. 1997. Waterborne protozoan pathogens. Clin. Microbiol. Rev. 10:67-85.
32. McCormack, J. J. 1975. Structure-activity relationships among pteridine derivatives and related quinazolines as inhibitors of dihydrofolate reductase, p. 125-132. In W. Pfleiderer (ed.), Chemistry and biology of pleridines. de Gruyter, New York, N.Y.
33. Miyajima, A., I. Miyajima, K. Arai, and N. Arai. 1984. Expression of plasmid R388-encoded type II dihydrofolate reductase as a dominant selective marker in Saccharomyces cerevisiae. Mol. Cell. Biol. 4:407-414.
34. Moir, D. T., T. E. Dorman, A. P. Smyth, and D. R. Smith. 1993. A human genome YAC library in a selectable high-copy-number vector. Gene 125: 229-232.
35. Morgan, U. M., C. C. Constantine, P. O'Donoghue, B. P. Meloni, P. A. O'Brien, and R. C. Thompson. 1995. Molecular characterization of Cryptosporidium isolates from humans and other animals using random amplified polymorphic DNA analysis. Am. J. Trop. Med. Hyg. 52:559-564.
36. Mumberg, D., R. Muller, and M. Funk. 1995. Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene 156:119-122.
37. Peng, M. M., L. Xiao, A. R. Freeman, M. J. Arrowood, A. A. Escalante, A. C. Weltman, C. S. Ong, W. R. Mac Kenzie, A. A. Lal, and C. B. Beard. 1997. Genetic polymorphism among Cryptosporidium parvum isolates: evidence of two distinct human transmission cycles. Emerg. Infect. Dis. 3:567-573.
38. Peters, W. 1987. Chemotherapy and drug resistance in malaria, 2nd ed. Academic Press, London, United Kingdom.
39. Poe, M. 1976. Antibacterial synergism: a proposal for chemotherapeutic potentiation between trimethoprim and sulfamethoxazole. Science 194:533-535.
40. Prendergast, N. J., T. J. Delcamp, P. L. Smith, and J. H. Freisheim. 1988. Expression and site-directed mutagenesis of human dihydrofolate reductase. Biochemistry 27:3664-3671.
41. Reisberg, B., J. Herzog, and L. Weinstein. 1966. In vitro antibacterial activity of trimethoprim alone and combined with sulfonamides. Antimicrob. Agents Chemother. 6:424-429.
42. Roos, D. S. 1993. Primary structure of the dihydrofolate reductase-thymidylate synthase gene from Toxoplasma gondii. J. Biol. Chem. 268:6269-6280.
43. Rose, J. B. 1997. Environmental ecology of Cryptosporidium and public health implications. Annu. Rev. Public Health 18:135-161.
44. Rosowsky, A., K. K. N. Chen, and M. Lin. 1972. 2,4-Diaminothieno[2,3-d] pyrimidines as antifolates and antimalarials. 3. Synthesis of 5,6-disubstituted derivatives and related tricyclic analogues. J. Heterocycl. Chem. 9:775-782.
45. Rosowsky, A., K. K. N. Chen, M. E. Nadel, N. Papathanasopoulos, and E. J. Modest. 1972. Quinazolines. VIII. Synthesis of 1,3-diaminobenzo[f]quinazolines. J. Heterocycl. Chem. 9:275-283.
46. Rosowsky, A., K. K. M. Chen, N. Papathanasopoulos, and E. J. Modest. 1972. Quinazolines. VII. Synthesis of 1,3-diamino-5,6-dihydrobenzo[f]quinazolines. J. Heterocycl. Chem. 9:263-273.
47. Rosowsky, A., A. S. Dey, J. Battaglia, and E. J. Modest. 1969. Synthesis of 2,4-diamino-9H-indeno[2,1-d]pyrimidines. J. Heterocycl. Chem. 6:613-622.
48. Rosowsky, A., R. A. Forsch, and S. F. Queener. 1995. 2,4-Diaminopyrido[3.2-d]pyrimidine inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii. J. Med. Chem. 38:2615-2620.
49. Rosowsky, A., J. B. Hynes, and S. F. Queener. 1995. Structure-activity and structure-selectivity studies on diaminoquinazolines and other inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase. Antimicrob. Agents Chemother. 39:79-86.
50. Rosowsky, A., J. L. Marini, M. E. Nadel, and E. J. Modest. 1970. Quinazolines. VI. Synthesis of 2,4-diaminoquinazolines from anthranilonitriles. J. Med. Chem. 13:882-886.
51. Rosowsky, A., C. E. Mota, and S. F. Queener. 1995. Synthesis and antifolate activity of 2,4-diamino-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine analogues of trimetrexate and piritrexim. J. Heterocycl. Chem. 32:335-340.
52. Rosowsky, A., C. E. Mota, S. F. Queener, M. Waltham, E. Ercikan Abali, and J. R. Bertino. 1995. 2,4-Diamino-5-substituted-quinazolines as inhibitors of a human dihydrofolate reductase with a site-directed mutation at position 22 and of the dihydrofolate reductases from Pneumocystis carinii and Toxoplasma gondii. J. Med. Chem. 38:745-752.
53. Rosowskj, A., C. E. Mota, J. E. Wright, J. H. Freisheim, J. J. Heusner, J. J. McCormack, and S. F. Queener. 1993. 2,4-Diaminothieno[2,3-d]pyrimidine analogues of trimetrexate and piritrexim as potential inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase. J. Med. Chem. 36:3103-3112.
54. Rosowsky, A., C. E. Mota, J. E. Wright, and S. F. Queener. 1994. 2,4-Diamino-5-chloroquinazoline analogues of trimetrexate and piritrexim: synthesis and antifolate activity. J. Med. Chem. 37:4522-4528.
55. Rosowsky, A., A. T. Papoulis, R. A. Forsch, and S. F. Queener. 1999. Synthesis and antiparasitic and antitumor activity of 2,4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim. J. Med. Chem. 42: 1007-1017.
56. Rosowsky, A., A. T. Papoulis, and S. F. Queener. 1997. 2,4-Diaminothieno [2,3-d]pyrimidine lipophilic antifolates as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase. J. Med. Chem. 40:3694-3699.
57. Sibley, C. H., V. H. Brophy, S. Cheesman, K. L. Hamilton, E. G. Hankins, J. M. Wooden, and B. Kilbey. 1997. Yeast as a model system to study drugs effective against apicomplexan proteins. Methods 13:190-207.
58. Sikorski, R. S., and P. Hieter. 1989. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122:19-27.
59. Sirotnak, F. M. 1984. Folate antagonists as therapeutic agents. Academic Press, New York, N.Y.
60. Spano, F., L. Putignani, J. McLauchlin, D. P. Casemore, and A. Crisanti. 1997. PCR-RFLP analysis of the Cryptosporidium oocyst wall protein (COWP) gene discriminates between C. wrairi and C. parvum. and between C. parvum isolates of human and animal origin. FEMS Microbiol. Lett. 150:209-217.
61. Vasquez, J. R., L. Gooz'e, K. Kim, J. Gut, C. Petersen, and R. G. Nelson. 1996. Potential antifolate resistance determinants and genotypic variation in the bifunctional dihydrofolate reductase-thymidylate synthase gene from human and bovine isolates of Cryptosporidium parvum. Mol. Biochem. Parasitol. 79:153-165.
62. Warner, P., and A. C. Maniar. 1966. Combined action of sulfadiazine and trimethoprim. Appl. Microbiol. 14:299-300.
63. Welch, A. D. 1983. Folic acid: discovery and the exciting first decade. Perspect. Biol. Med. 27:64-75.
64. Wooden, J. M., L. H. Hartwell, B. Vasquez, and C. H. Sibley. 1997. Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum. Mol. Biochem. Parasitol. 85:25-40.
65. Woods, K. M., M. V. Nesterenko, and S. J. Upton. 1996. Efficacy of 101 antimicrobials and other agents on the development of Cryptosporidium parvum in vitro. Ann. Trop. Med. Parasitol. 90:603-615.
66. Zhou, Y. H., X. P. Zhang, and R. H. Ebright. 1991. Random mutagenesis of gene-sized DNA molecules by use of PCR with Taq DNA polymerase. Nucleic Acids Res. 19:6052.